Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The goal of this observational study is to see if there is a cyclical or exaggerated diurnal variation in aldosterone production in people with Primary Aldosteronism.
The main questions it aims to answer are:
Participants will have a 24 hour urine measurement. They will also have multiple blood tests throughout the day to study the variability in aldosterone secretion.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Sensitivity and specificity of 24 hour urine tetrahydroaldosterone excretion. | Can measurement of 24 hour urine tetrahydroaldosterone excretion detect more people with PA than current conventional screening tests? | 12 months |
| Measure | Description | Time Frame |
|---|---|---|
| Differences in timed day and night urine THA measurements. | We will be measuring the 24 hour urine THA samples in two separate (approximately 12 hours each) collections, one in the day and one at night. We can then study if there are any differences between day time and night time secretion which may help us understand the diurnal variation in aldosterone secretion. | 12 months |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
People with hypertension.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Yun Ni Lee | Contact | +442078827275 | y.n.lee@qmul.ac.uk | |
| Tumi Kaminskas | Contact | +442078827275 | research.governance@qmul.ac.uk |
| Name | Affiliation | Role |
|---|---|---|
| William Drake, Prof | Queen Mary University of London | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Queen Mary University of London | Recruiting | London | United Kingdom |
Not provided
| ID | Term |
|---|---|
| D006929 | Hyperaldosteronism |
| D006973 | Hypertension |
| ID | Term |
|---|---|
| D000308 | Adrenocortical Hyperfunction |
| D000307 | Adrenal Gland Diseases |
| D004700 | Endocrine System Diseases |
| D014652 | Vascular Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Urine and whole blood.
| Variation in aldosterone secretion from day series in those with positive 24h urine THA and those with negative 24h urine THA. | This will allow us to study further if the reason why their screening blood test did not meet the threshold for diagnosis. | 12 months |
| Complete or partial clinical cure rate of this cohort of patients that qualify for adrenalectomy | Complete clinical cure is daytime home or ambulatory BP < 135/<85mmHg, on no treatment. Partial clinical cure is BP < 135/<85 mmHg on the same or fewer drugs, not including a K+-sparing diuretic. | 12 months |
| Complete biochemical cure of PA in this cohort of patients that qualify for adrenalectomy. | This is defined as (whilst off medications that might alter serum potassium or the RAS) by both:
| 12 months |
| D002318 | Cardiovascular Diseases |